Stock Events

Stock Events

Spero Therapeutics (2HA.F) Q1 2026 Earnings

26MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.49

-0.17

0.14

0.46

Details

Expected EPS

-0.17328

Actual EPS

0.459192

Surprise EPS

0.63

Surprise Percent

+365%

Description

Spero Therapeutics (2HA.F) has reported earnings of 0.459192 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.